Investigating the Clinical Utility of the Oxford Virtual Autism Assessment Tool (OVAAT)

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of the study is to evaluate a new Autism Spectrum Disorder (ASD) diagnostic tool (Oxford Virtual Autism Assessment Tool (OVAAT)) to see whether it can: * Be able to identify autistic traits * Be able to distinguish between autistic and non-autistic young people * Is the tool better, similar or worse than another evidence-based observational tool (ADOS-2) in identifying features of autism?

Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Maximum Age: 18
Healthy Volunteers: t
View:

• Group 1: 13-18 year old young people waiting for an autism assessment in the Oxfordshire CAMHS Neurodevelopmental Conditions (NDC) pathway who have access to and are able to use a laptop or desktop computer and a quiet place to complete the assessment.

• Group 2: 13-18 year old young people with no neurodevelopmental or mental health conditions who have access to and are able to use a laptop or desktop computer and a quiet place to complete the assessment.

Locations
Other Locations
United Kingdom
Oxford Health NHS Foundation Trust
RECRUITING
Oxford
Contact Information
Primary
Sophie Chalker
ovaat.study@oxfordhealth.nhs.uk
+441865 902447
Backup
James Stacey
ovaat.study@oxfordhealth.nhs.uk
+441865 902447
Time Frame
Start Date: 2023-09-22
Estimated Completion Date: 2025-05
Participants
Target number of participants: 60
Treatments
Experimental: Autistic
This will be participants who are waiting for an autism assessment in the Oxfordshire CAMHS Neurodevelopmental Conditions (NDC) pathway. The participant are will complete the OVAAT and an ADOS-2 assessment.~The participant will have a neurodevelopmental assessment using the ADOS-2 is an existing tool that we use to assess autism and a developmental history - this is the current standard assessment process. They will receive feedback from this appointment. The second appointment will be using the OVAAT. This assessment will be video and audio recorded (through Microsoft Teams) so that we can check whether another clinical researcher comes to the same conclusion as the person providing the OVAAT. We will only keep the recording until the 2nd researcher has watched and listened to the recording.
Experimental: Neurotypical
These participants will be neurotypical young people recruited from the general population of Oxfordshire. They will only receive an OVAAT appointment.~The participants will first complete screening measures to assess their eligibility for the study. If they are still eligible, an OVAAT appointment will be arranged. This will be the same process as group 1. This assessment will be video and audio recorded (through Microsoft Teams) so that we can check whether another clinical researcher comes to the same conclusion as the person providing the OVAAT. We will only keep the recording until the 2nd researcher has watched and listened to the recording.
Related Therapeutic Areas
Sponsors
Leads: Oxford Health NHS Foundation Trust

This content was sourced from clinicaltrials.gov